Skip to main content

Posts

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.

Published on: February 12, 2026 at 11:00PM Conditions : Muscle Wasting; Obesity & Overweight; Obesity Interventions : Drug: BIO101; Other: Placebo; Drug: Semaglutide Sponsors : Biophytis Not yet recruiting https://ift.tt/Ehb9wZU

Latest Posts

New diabetes clinical trial: Clinical Performance of Giomer-Based Composite Restorations in Class V Carious Lesions in Diabetic and Non-Diabetic Patients

New diabetes clinical trial: Effect of Insulin Lowering on Lipogenesis

New diabetes clinical trial: Impact of a Nutritional Intervention Based on Moroccan Dietary Habits on the Glycemic Control of Type 2 Diabetics

New diabetes clinical trial: The Role of Climate Change Education on Awareness, Concern, and Hope in Pregnant Women

New diabetes clinical trial: Effects of Ankle Block on Postoperative Analgesia in Diabetic and Non-Diabetic Patients

New diabetes clinical trial: Ayurveda Diet & Lifestyle Protocol for Type 2 Diabetes: A Feasibility Study

New diabetes clinical trial: Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

New diabetes clinical trial: Association Between Dry Eye Disease and Diabetic Macular Edema

New diabetes clinical trial: INVESTIGATION OF THE EFFECT OF DIFFERENT ACTIVATION TECHNIQUES ON TLR9, IL6, IL10, TNFα LEVELS IN HEALTHY AND TYPE 2 DIABETIC PATIENTS WITH APICAL PERIODONTITIS REQUIRING RETREATMENT

New diabetes clinical trial: To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years.